MEMORIA 2023 - Área 2. Enfermedades Cardiovasculares y Respiratorias

Área 2. Enfermedades Cardiovasculares y Respiratorias

OBJETIVOS CIENTÍFICOS VINCULADOS AL PLAN ESTRATÉGICO

Generar conocimiento científico de excelencia: se presenta un descenso en el número de trabajos publicados aunque hay un incremento importante en el porcentaje de primeros cuartiles.
Captación de talento científico: se ha producido un breve incremento del personal vinculado a la financiación de los grupos aunque se debe mejorar la captación de ayudas competitivas de recursos humanos.
Dinamizar la captación de recursos: la captación de recursos competitivos también se ha visto reducida pasando de 8 ayudas concedidas a 5. Sin embargo se ha producido un incremento muy notable en la facturación por ensayos clínicos incrementándose los ingresos en un 52%.

7 Grupos de Investigación

CARDIOLOGIA CLINICA Y EXPERIMENTAL (CONSOLIDADO)
INVESTIGACIÓN EN PEDIATRÍA (CONSOLIDADO)
TERAPIAS RESPIRATORIAS EN LA INSUFICIENCIA RESPIRATORIA AGUDA (CLÍNICO ASOCIADO)
AEROBIOLOGÍA Y TOXICOLOGÍA AMBIENTAL (EMERGENTE)
FISIOLOGÍA MÉDICA (EMERGENTE)
GRUPO DE INVESTIGACIÓN DE ENFERMERÍA EN AVANCES EN PRUEBAS FUNCIONALES RESPIRATORIAS (CLÍNICO ASOCIADO)
INVESTIGACIÓN Y DESARROLLO EN CIRUGÍA CARDIOVASCULAR (CLÍNICO ASOCIADO)

INDICADORES GENERALES

Nº Publicaciones

591.4

Impacto Total

7.3

Impacto Medio

Tipo	Nº Pubs	FI total	FI Medio
Originales	73 (90.12%)	561.2	7.69
Revisiones	8 (9.88%)	30.2	3.78

75.31

Q1%

17.28

D1%

FI >= 15

Tipo	Nº Q1	Nº D1	Nº FI >= 15
Originales	55	14	9
Revisiones	6	0	0

INDICADORES DE LIDERAZGO

36 (44.0%)

Nº Publicaciones

156.8

Impacto Total

4.36

Impacto Medio

	Nº Pubs	FI total	FI Medio
Mujer	9 (25.0%)	35.0	3.89
Hombre	27 (75.0%)	121.8	4.51

66.67

Q1%

13.89

D1%

FI >= 15

	Nº Q1	Nº D1	Nº FI >= 15
Mujer	9	2	0
Hombre	15	3	2

OTROS INDICADORES

32.69

HCP10% (2019-2023)

27.45

HCP10 Liderado% (2019-2023)

9.8

HCP10 Lid. Mujeres% (2019-2023)

4.29

Crown (2019-2023)

77.78

Open Access%

58.02

Col. International%

* Se muestran las 5 especies, los 10 genes y las 20 enfermedades más nombradas. Los valores están normalizados logarítmicamente en base al número de publicaciones.

INDICADORES EVOLUTIVOS

DESTACADAS

Garcia-Marcos L, Chiang CY, Asher MI, ..., Morales E. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study. Lancet Global Health, 2023, 11, e218-e228, PMID: 36669806, FI: 19.9

Pascual-Figal DA, Zamorano JL, Domingo M et al. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study. European Journal of Heart Failure, 2023, 25, 1352-1360, PMID: 37211950, FI: 16.9

Martinez-Montesinos L, Rivera-Caravaca JM*, Agewall S, ..., Roldan V*. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomedicine & Pharmacotherapy, 2023, 158, 114064, PMID: 36495662, FI: 6.9

Valverde-Molina J*, Fernandez-Nieto M, Torres-Borrego J et al. Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus. Journal of Investigational Allergology and Clinical Immunology, 2023, 33, 179-189, PMID: 35029151, FI: 6.1

Barreiro-Perez M, Pastor Pueyo P, Raposeiras-Roubin S, ..., Pascual Figal D*. Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management. , 2023, 76, 555-563, PMID: 36914023, FI: 5.9

LISTADO COMPLETO

Stambler BS, Camm AJ, Alings M et al. COLABORADORES: Ip JE, Jones A Sr, Stambler BS, ..., Pascual-Figal D et al. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. Lancet, 2023, 402, 118-128, PMID: 37331368, FI: 98.4

Arbelo E, Protonotarios A, Gimeno JR et al. 2023 ESC Guidelines for the management of cardiomyopathies. European Heart Journal, 2023, ehad194 [pii], PMID: 37622657, FI: 37.6

Hochman JS, Anthopolos R, Reynolds HR et al. COLABORADORES: Hochman JS, Maron DJ, Reynolds HR, ..., Marin F et al. Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation, 2023, 147, 8-19, PMID: 36335918, FI: 35.5

Siguero-Alvarez M, Salguero-Jimenez A, Grego-Bessa J, ..., Gomez MJ et al. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve. Circulation, 2023, 147, 47-65, PMID: 36325906, FI: 35.5

Kuter DJ, Bonkovsky HL, Monroy S, ..., Guillen-Navarro E et al. Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. Journal of Hepatology, 2023, 79, 1150-1158, PMID: 37479139, FI: 26.8

Sanchis J, Bueno H, Minana G, ..., Marin F et al. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial. Jama Internal Medicine, 2023, 183, 407-415, PMID: 36877502, FI: 22.5

McEwan P, Harrison C, Binnie R, ..., Pascual-Figal DA et al. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalisation: A European multinational economic evaluation. European Journal of Heart Failure, 2023, 10.1002/ejhf.2788 [doi], PMID: 36718652, FI: 16.9

Lorenzo M, Jacobs-Cacha C, Palau P et al. COLABORADORES: Palau P, Amiguet M, Dominguez E, ..., Pascual-Figal D et al. Short-Term Changes in Peak VO(2) After Initiation of Dapagliflozin in Heart Failure Across Iron Status. Jacc-Heart Failure, 2023, 11, 1611-1622, PMID: 37676213, FI: 10.3

Costa-Gomez I, Suarez-Suarez M, Moreno JM et al. A novel application of thermogravimetry-mass spectrometry for polystyrene quantification in the PM(10) and PM(2.5) fractions of airborne microplastics. Science of the Total Environment, 2023, 856, 159041, PMID: 36174703, FI: 8.2

Iliodromitis K, Lenarczyk R, Scherr D, ..., Marin F et al. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey. Europace, 2023, 25, 667-675, PMID: 36512365, FI: 7.9

Lewis EA, Muniz-Anquela R, Redondo-Angulo I et al. Capacity for LDL (Low-Density Lipoprotein) Retention Predicts the Course of Atherogenesis in the Murine Aortic Arch. Arteriosclerosis Thrombosis and Vascular Biology, 2023, 43, 637-649, PMID: 36794588, FI: 7.4

Bermudez-Jimenez FJ, Carriel V, Santos-Mateo JJ, ..., Gimeno Blanes JR et al. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium. Revista Espanola de Cardiologia, 2023, 76, 301-311, PMID: 35952944, FI: 7.2

Galian-Gay L, Teixido-Tura G, Casas G, ..., Saura D et al. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis. European Heart Journal-Cardiovascular Imaging, 2023, 24, 1120-1128, PMID: 37131301, FI: 6.7

Cannie DE, Protonotarios A, Bakalakos A, ..., Gimeno JR et al. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants. Circulation-Genomic and Precision Medicine, 2023, 16, 434-441, PMID: 37593875, FI: 6.0

Vivas D, Anguita-Gamez M, Ferrandis R, ..., Marin F*. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in "real world": the REQXAA study. , 2023, 76, 729-738, PMID: 36914025, FI: 5.9

Cano O, Bazan V, Arana E et al. COLABORADORES: Alcalde-Rodriguez O, Almendral-Garrote J, Alonso-Fernandez P, ..., Penafiel-Verdu P et al. Spanish catheter ablation registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2022). , 2023, 76, 910-921, PMID: 37730116, FI: 5.9

Hernandez-Vaquero D, Rodriguez-Caulo E, Vigil-Escalera C, ..., Canovas S et al. Life expectancy after surgical aortic valve replacement for low-gradient aortic stenosis with preserved ejection fraction. , 2023, 76, 32-39, PMID: 35732565, FI: 5.9

Martinez-Solano J, Ortiz-Bautista C, Gutierrez-Ibanes E, ..., Garcia-Lara J* et al. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study. , 2023, 76, 312-321, PMID: 36155847, FI: 5.9

Diego-Nieto A, Nunez JC, Minana G, ..., Lacunza J* et al. Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions. , 2023, 76, 253-260, PMID: 35691552, FI: 5.9

Fawzy AM, Rivera-Caravaca JM, Underhill P et al. Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database. Diabetes Obesity & Metabolism, 2023, 25, 602-610, PMID: 36054168, FI: 5.4

Diez-Diez M, Amoros-Perez M, de la Barrera J, ..., Pascual-Figal DA* et al. Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. Geroscience, 2023, 45, 1231-1236, PMID: 35752705, FI: 5.3

Amate-Garcia G, Ballesta-Martinez MJ, Serrano-Lorenzo P et al. A Novel Mutation Associated with Neonatal Lethal Cardiomyopathy Leads to an Alternative Transcript Expression in the X-Linked Complex I NDUFB11 Gene. International Journal of Molecular Sciences, 2023, 24, PMID: 36675256, FI: 4.9

Del Monte-Monge A, Ruiz-Polo de Lara I, Gonzalo P, ..., Gimeno JR et al. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction. International Journal of Molecular Sciences, 2023, 24, PMID: 37446344, FI: 4.9

Moriki D, Antonogeorgos G, Koumpagioti D, ..., Garcia-Marcos L et al. Adherence to an Anti-Inflammatory Diet and Atopic Diseases' Prevalence in Adolescence: The Greek Global Asthma Network Study. Nutrients, 2023, 15, PMID: 37513609, FI: 4.8

Nadarajah R, Ludman P, Laroche C et al. COLABORADORES: Vahanian A, Budaj A, Dagres N, ..., Marin F et al. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology. European Heart Journal-Quality of Care and Clinical Outcomes, 2023, 9, 552-563, PMID: 36737420, FI: 4.8

Valverde-Molina J*, Garcia-Marcos L*. Microbiome and Asthma: Microbial Dysbiosis and the Origins, Phenotypes, Persistence, and Severity of Asthma. Nutrients, 2023, 15, PMID: 36771193, FI: 4.8

Lopez-Galvez R*, Rivera-Caravaca JM, Mandaglio-Collados D, ..., Marin F*. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. Faseb Journal, 2023, 37, e22941, PMID: 37115741, FI: 4.4

Rivera-Caravaca JM, Roldan V*, Martinez-Montesinos L, ..., Marin F. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. Journal of General Internal Medicine, 2023, 38, 315-323, PMID: 35411538, FI: 4.3

Vizmanos B, Cascales AI, Rodriguez-Martin M, ..., Garaulet M. Lifestyle mediators of associations among siestas, obesity, and metabolic health. Obesity, 2023, 31, 1227-1239, PMID: 37140401, FI: 4.2

Visniauskas B, Reverte V, Abshire CM et al. High-plasma soluble prorenin receptor is associated with vascular damage in male, but not female, mice fed a high-fat diet. American Journal of Physiology-Heart and Circulatory Physiology, 2023, 324, H762-H775, PMID: 36930656, FI: 4.1

Abumayyaleh M, Nunez Gil IJ, Viana-LLamas MC, ..., Marin F et al. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry. Frontiers in Endocrinology, 2023, 14, 1167087, PMID: 37260447, FI: 3.9

Amiguet M, Palau P, Dominguez E et al. COLABORADORES: Domingueza E, Sastre C, Minana G, ..., Pascual-Figal D et al. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction. Scientific Reports, 2023, 13, 10591, PMID: 37391470, FI: 3.8

Lopez-Galvez R, Rivera-Caravaca JM, Roldan V, ..., Marin F. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. American Heart Journal, 2023, 258, 1-16, PMID: 36526006, FI: 3.7

Irving M, AlSayed M, Arundel P, ..., Guillen-Navarro E et al. European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis. Orphanet Journal of Rare Diseases, 2023, 18, 219, PMID: 37501185, FI: 3.4

Ballesta-Martinez MJ, Perez-Fernandez V, Lopez-Gonzalez V, ..., Guillen-Navarro E. Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice. Orphanet Journal of Rare Diseases, 2023, 18, 201, PMID: 37480025, FI: 3.4

Alanay Y, Mohnike K, Nilsson O, ..., Guillen-Navarro E et al. Real-world evidence in achondroplasia: considerations for a standardized data set. Orphanet Journal of Rare Diseases, 2023, 18, 166, PMID: 37365619, FI: 3.4

Maghnie M, Semler O, Guillen-Navarro E et al. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. Orphanet Journal of Rare Diseases, 2023, 18, 56, PMID: 36922864, FI: 3.4

Sanchez R, Ripoll-Vera T, Lopez-Mendoza M, ..., Gimeno JR et al. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants. Orphanet Journal of Rare Diseases, 2023, 18, 8, PMID: 36624527, FI: 3.4

Proietti R, Rivera-Caravaca JM, Harrison SL et al. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis. Internal and Emergency Medicine, 2023, 18, 423-428, PMID: 36640228, FI: 3.2

Garcia-Tudela A, Simonelli-Munoz AJ, Gallego-Gomez JI, Rivera-Caravaca JM*. Impact of the COVID-19 pandemic on stress and sleep in emergency room professionals. Journal of Clinical Nursing, 2023, 32, 5037-5045, PMID: 37132445, FI: 3.2

Lopez-Rodriguez R, Ruiz-Hornillos J, Corton M, ..., Barreda-Sanchez M et al. Androgen receptor polyQ alleles and COVID-19 severity in men: A replication study. Andrology, 2023, 11, 24-31, PMID: 36375449, FI: 3.2

Witte KK, Wachter R, Senni M, ..., Pascual-Figal D*. Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure. Esc Heart Failure, 2023, 10, 80-89, PMID: 36125177, FI: 3.2

Lopez-Palop R, Carrillo P, Leithold G, ..., Pascual D. Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation. International Journal of Cardiology, 2023, 383, 8-14, PMID: 37085119, FI: 3.2

Blanco-Morillo J*, Salmeron Martinez D, Morillo-Cuadrado DV, ..., Canovas-Lopez S*. Hematic Antegrade Repriming Reduces Emboli on Cardiopulmonary Bypass: A Randomized Controlled Trial. Asaio Journal, 2023, 69, 324-331, PMID: 35609139, FI: 3.1

Garcia-Serna AM*, Morales E*, Cantero-Cano E, ..., Martin-Orozco E*. Cytokine production by newborns: influence of sex and season of birth. Pediatric Research, 2023, 93, 526-534, PMID: 35945266, FI: 3.1

Fernandez-Paredes PC, Morales E, Lopez-Soler C, Garcia-Marcos L*. Does Asthma Disrupt Psychological Wellbeing in Pregnancy? Journal of Clinical Medicine, 2023, 12, PMID: 37834979, FI: 3.0

Carcavilla A, Cambra A, Santome JL, ..., Guillen-Navarro E et al. Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. Journal of Clinical Medicine, 2023, 12, PMID: 37568403, FI: 3.0

Vitolo M, Proietti M, Imberti JF, ..., Marin F et al. Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients. Journal of Clinical Medicine, 2023, 12, PMID: 36769416, FI: 3.0

Nunez-Gil IJ, Feltes G, Viana-Llamas MC, ..., Marin F et al. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2). Journal of Clinical Medicine, 2023, 12, PMID: 36675633, FI: 3.0

Proietti R, Rivera-Caravaca JM, Lopez-Galvez R et al. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. Journal of Clinical Medicine, 2023, 12, PMID: 37109151, FI: 3.0

Bucci T, Mbizvo GK, Rivera-Caravaca JM et al. Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy. Current Problems in Cardiology, 2023, 48, 101868, PMID: 37295636, FI: 3.0

Porlan MV, Tello-Montoliu A, Lopez-Garcia C et al. Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients. , 2023, 46, 101195, PMID: 37032997, FI: 2.9

Herrero-Brocal M, Marin F, Valverde L et al. High medium-term incidence of major cardiovascular events in discharged patients with unstable angina. , 2023, 46, 101209, PMID: 37152426, FI: 2.9

Parra A, Rabin R, Pappas J, ..., Ballesta-Martinez MJ et al. Clinical Heterogeneity and Different Phenotypes in Patients with SETD2 Variants: 18 New Patients and Review of the Literature. Genes, 2023, 14, PMID: 37372360, FI: 2.8

Schneider H, Hadj-Rabia S, Faschingbauer F, ..., Guillen-Navarro E et al. Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia. Genes, 2023, 14, PMID: 36672894, FI: 2.8

Millesimo M, Elia E, Marengo G, ..., Manzano-Fernandez S* et al. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry. American Journal of Cardiovascular Drugs, 2023, 23, 77-87, PMID: 36316613, FI: 2.8

Parisi V, Baldassarre R, Ferrara V, ..., Gimeno Blanes JR et al. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking. Frontiers in Cardiovascular Medicine, 2023, 10, 1184361, PMID: 37416917, FI: 2.8

Robles-Mezcua A, Ruiz-Salas A, Medina-Palomo C, ..., Gimeno-Blanes JR et al. The Novel Variant NP_00454563.2 (p.Glu259Glyfs*77) in Gene PKP2 Associated with Arrhythmogenic Cardiomyopathy in 8 Families from Malaga, Spain. Genes, 2023, 14, PMID: 37510372, FI: 2.8

Diaz-Garcia C, Valverde-Molina J*, Martinez-Gimeno A et al. Quality of life in children with diseases causing central airway obstruction: Reliability and validity of the TAPQOL questionnaire. Pediatric Pulmonology, 2023, 58, 279-287, PMID: 36207999, FI: 2.7

Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, ..., Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Medicina Clinica, 2023, 161, 185-191, PMID: 37137804, FI: 2.6

Mandaglio-Collados D, Marin F, Rivera-Caravaca JM*. Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment. Medicina Clinica, 2023, 161, 344-350, PMID: 37517924, FI: 2.6

Arribas-Leal JM, Rivera-Caravaca JM, Hernandez-Torres A, ..., Herrero-Martinez JA. Incidence and predictors of sternal surgical wound infection in cardiac surgery: A prospective study. International Wound Journal, 2023, 20, 917-924, PMID: 36168924, FI: 2.6

Larranaga-Moreira JM, Rodriguez-Serrano AI, Dominguez F et al. Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry. Medicina Clinica, 2023, 161, 476-482, PMID: 37684159, FI: 2.6

Bercedo-Sanz A, Martinez-Torres A, Varela AL et al. Prevalence and time trends of symptoms of allergic rhinitis and rhinoconjunctivitis in Spanish children: Global Asthma Network (GAN) study. Allergologia et Immunopathologia, 2023, 51, 1-11, PMID: 37695222, FI: 2.5

Ahmetaj L, Martinez-Torres AE, Ahmetaj Y, ..., Garcia-Marcos L*. The role of Human Development Index in the epidemiology of asthma in adolescents in Kosovo: A cross-sectional multicentre Global Asthma Network (GAN) study. Allergologia et Immunopathologia, 2023, 51, 59-70, PMID: 36916089, FI: 2.5

Alvarez-Ortega CA, Ruiz MA, Solorzano-Guillen C, ..., Garcia-Alberola A et al. Time to -30 degrees C as a predictor of acute success during cryoablation in patients with atrial fibrillation. Cardiology Journal, 2023, 30, 534-542, PMID: 34708863, FI: 2.5

Ding WY, Romero-Aniorte AI, Tello-Montoliu A, ..., Rivera-Caravaca JM*, Marin F*. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia. Heart & Lung, 2023, 59, 61-66, PMID: 36739642, FI: 2.4

Proietti R, Rivera-Caravaca JM*, Lopez-Galvez R et al. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. Clinical Cardiology, 2023, 46, 656-662, PMID: 37038622, FI: 2.4

Rivera-Caravaca JM*, Anguita Sanchez M, Sanmartin Fernandez M, ..., Marin F*. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment. American Journal of Cardiology, 2023, 203, 122-127, PMID: 37487406, FI: 2.3

Garcia-Martinez VE, Galiana-Valles X, Zomeno-Alcala O, ..., Guillen-Navarro E. Dental Phenotype with Minor Ectodermal Symptoms Suggestive of WNT10A Deficiency. Children-Basel, 2023, 10, PMID: 36832485, FI: 2.0

Soler-Espejo E, Esteve-Pastor MA, Rivera-Caravaca JM, ..., Marin F*. Reducing bleeding risk in patients on oral anticoagulation therapy. , 2023, , 1-14, PMID: 37905915, FI: 2.0

Marin F, Fernandez MS, Baron-Esquivias G et al. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of Comparative Effectiveness Research, 2023, 12, e220049, PMID: 36749006, FI: 1.9

Garcia-Tudela A, Simonelli-Munoz AJ, Jimenez-Rodriguez D, ..., Rivera-Caravaca JM et al. Sleep analysis of hospital and out-of-hospital emergency professionals. International Emergency Nursing, 2023, 71, 101352, PMID: 37738910, FI: 1.8

Urrutia-Pereira M, Mocelin LP, Ellwood P, Garcia-Marcos L et al. Prevalence of rhinitis and associated factors in adolescents and adults: a Global Asthma Network study. , 2023, 41, e2021400, PMID: 36888752, FI: 1.7

Jurado-Roman A, Minana G, Salinas P, ..., Lacunza J* et al. Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry. Minerva Cardiology and Angiology, 2023, 71, 284-293, PMID: 35420282, FI: 1.4

Arbelo E, Protonotarios A, Gimeno JR et al. [2023 ESC Guidelines for the management of cardiomyopathies]. , 2023, 24, e1-e127, PMID: 37901944, FI: 0.5

AYUDAS CONCEDIDAS EN 2023

TOTAL DE AYUDAS CONCEDIDAS

Nº Ayudas

1.12M €

Financiación

TOTAL DE AYUDAS RECURSOS HUMANOS CONCEDIDAS

Nº Ayudas

0.0M €

Financiación

TOTAL DE AYUDAS PROYECTOS I+D+i CONCEDIDAS

Nº Ayudas Europeas

0.0M €

Financiación Europea

Nº Ayudas Nacionales

0.33M €

Financiación Nacional

Nº Ayudas Regionales

0.29M €

Financiación Regional

TOTAL DE REDES CONCEDIDAS

Nº Ayudas

0.51M €

Financiación

OTRAS AYUDAS COMPETITIVAS CONCEDIDAS (MOVILIDAD, ORGANIZACIÓN DE EVENTOS CIENTÍFICOS, ...)

Nº Ayudas

0.0K €

Financiación

PROYECTOS DE I+D+i Y AYUDAS DE RRHH ACTIVAS EN 2023

TOTAL AYUDAS

RECURSOS HUMANOS

REDES

PROYECTOS INTERNACIONALES

PROYECTOS NACIONALES

PROYECTOS REGIONALES

INICIADA EN 2023

Nº Estudios

Nº Ensayos Clínicos

Nº Producto Sanitario

Nº Estudios Post-Autorización

Nº Otros Estudios

ACTIVOS EN 2023

108

Nº Estudios

Nº Ensayos Clínicos

Nº Producto Sanitario

Nº Estudios Post-Autorización

Nº Otros Estudios

FACTURACIÓN EN 2023

0.58M €

Facturado

Nº Tesis (0 con mención internacional)